Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 22

Trial Status

Completed3

Role Distribution

Principal Investigator1
Other Roles2
PI Rate33%

Activity Timeline

Clinical Trials (3)

NCT03106844Phase 1/2Completed
The ICON Study: Outcomes After FMT for Patients With IBD and CDI
Clostridium Difficile InfectionInflammatory Bowel Diseases
PrincipalinvestigatorStart date: 2017-08-01
NCT02741518Phase 1/2Completed
Fecal Microbiota Transplantation for the Treatment of Obesity
Obesity
StudydirectorStart date: 2017-04-01
NCT02200445Phase 1Completed
Low Dose IL-2 for Ulcerative Colitis
Ulcerative Colitis
Studydirector

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03106844Phase 1/2PrincipalInvestigator

The ICON Study: Outcomes After FMT for Patients With IBD and CDI

Clostridium Difficile InfectionInflammatory Bowel Diseases
Completed
NCT02741518Phase 1/2StudyDirector

Fecal Microbiota Transplantation for the Treatment of Obesity

Obesity
Completed
NCT02200445Phase 1StudyDirector

Low Dose IL-2 for Ulcerative Colitis

Ulcerative Colitis
Completed

All 3 trials loaded